Search Results - "Sharafkhah, M"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study by Katoonizadeh, A., Sharafkhah, M., Ostovaneh, M. R., Norouzi, A., Khoshbakht, N., Mohamadkhani, A., Eslami, L., Gharravi, A., Shayanrad, A., Khoshnia, M., Esmaili, S., George, J., Poustchi, H., Malekzadeh, R.

    Published in Journal of viral hepatitis (01-10-2016)
    “…Summary We evaluated the immune response to neonatal HBV immunization in children of infected parents 10–18 years after primary vaccination. Healthy…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Hypertension and mortality in the Golestan Cohort Study: A prospective study of 50 000 adults in Iran by Sepanlou, S G, Sharafkhah, M, Poustchi, H, Malekzadeh, M M, Etemadi, A, Khademi, H, Islami, F, Pourshams, A, Pharoah, P D, Abnet, C C, Brennan, P, Boffetta, P, Dawsey, S M, Esteghamati, A, Kamangar, F, Malekzadeh, R

    Published in Journal of human hypertension (01-04-2016)
    “…High blood pressure has been the second most important determinant of disease burden in Iran since the 1990s. Despite well-recognized evidence on the…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Cost Utility Analysis of Infliixmab and Adalimumab Compared with Conventional Therapy in Patients with Crohn Disease in the Islamic Republic of Iran by Zaboli, P, Nikfar, S, Kebriaeezadeh, A, Malekzadeh, R, Akbari Sari, A, Sima, A, Abdollahi, M, Mirzaei, S, Sharafkhah, M, Rohani, E

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: In spite of expensive medication costs of Crohn Disease treatment, an economic evaluation has not been done locally in Islamic Republic of Iran…”
    Get full text
    Journal Article
  7. 7
  8. 8